Sierra Oncology Inc
NASDAQ:SRRA
Sierra Oncology Inc
EPS (Diluted)
Sierra Oncology Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sierra Oncology Inc
NASDAQ:SRRA
|
EPS (Diluted)
-$4
|
CAGR 3-Years
45%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
EPS (Diluted)
-$1
|
CAGR 3-Years
22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
EPS (Diluted)
-$1
|
CAGR 3-Years
9%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
EPS (Diluted)
$0
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
Spectral Medical Inc
TSX:EDT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
4%
|
See Also
What is Sierra Oncology Inc's EPS (Diluted)?
EPS (Diluted)
-4.9
USD
Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's EPS (Diluted) amounts to -4.9 USD.
What is Sierra Oncology Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
36%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Sierra Oncology Inc have been 45% over the past three years , 36% over the past five years .